RECRUITING

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Official Title

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Quick Facts

Study Start:2010-06-04
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04022616

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age or older
  2. * Ability to give informed consent
  3. * Stage I-III breast malignancy
  1. * Unable to tolerate venipuncture

Contacts and Locations

Study Contact

Ohio State Comprehensive Cancer Center
CONTACT
1-800-293-5066
OSUCCCClinicaltrials@osumc.edu

Principal Investigator

William Carson, MD
PRINCIPAL_INVESTIGATOR
Ohio State Comprehensive Cancer Center

Study Locations (Sites)

Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210
United States

Collaborators and Investigators

Sponsor: Ohio State University Comprehensive Cancer Center

  • William Carson, MD, PRINCIPAL_INVESTIGATOR, Ohio State Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2010-06-04
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2010-06-04
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer